Temozolomide in aggressive pituitary adenomas and carcinomas.

Clinics
Leon D OrtizKalman Kovacs

Abstract

Temozolomide is an alkylating agent used in the treatment of gliomas and, more recently, aggressive pituitary adenomas and carcinomas. Temozolomide methylates DNA and, thereby, has antitumor effects. O6-methylguanine-DNA methyltransferase, a DNA repair enzyme, removes the alkylating adducts that are induced by temozolomide, thereby counteracting its effects. A Medline search for all of the available publications regarding the use of temozolomide for the treatment of pituitary tumors was performed. To date, 46 cases of adenohypophysial tumors that were treated with temozolomide, including 30 adenomas and 16 carcinomas, have been reported. Eighteen of the 30 (60%) adenomas and 11 of the 16 (69%) carcinomas responded favorably to treatment. One patient with multiple endocrine neoplasia type 1 and an aggressive prolactin-producing adenoma was also treated and demonstrated a good response. No significant complications have been attributed to temozolomide therapy. Thus, temozolomide is an effective treatment for the majority of aggressive adenomas and carcinomas. Evidence indicates that there is an inverse correlation between levels of O6-methylguanine-DNA methyltransferase immunoexpression and therapeutic response. Alternatively, hi...Continue Reading

Citations

May 14, 2014·Nature Reviews. Endocrinology·Antonio Di IevaKalman Kovacs
Oct 17, 2012·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Ayca ErsenKalman Kovacs
Apr 23, 2013·Expert Opinion on Pharmacotherapy·Raquel S Jallad, Marcello D Bronstein
May 17, 2013·Expert Opinion on Pharmacotherapy·Vincenzo MarottaAntongiulio Faggiano
May 30, 2015·Expert Opinion on Emerging Drugs·Daniela Guelho, Ashley B Grossman
Oct 6, 2015·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Michael H Shanik
Dec 3, 2014·Neurologia Medico-chirurgica·Toshio HirohataAkira Matsuno
Feb 9, 2016·Expert Opinion on Drug Safety·Renata S AuriemmaAnnamaria Colao
Mar 17, 2015·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·James K LiuJean Anderson Eloy
Apr 13, 2011·PloS One·Apostolos ZaravinosDemetrios A Spandidos
Mar 12, 2017·Endocrine Pathology·Nicola TuftonMárta Korbonits
Jan 27, 2015·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·R E StrowdJ J Laterra
Mar 15, 2018·Endocrine-related Cancer·Luis V SyroKalman Kovacs
May 16, 2013·Journal of Neuro-oncology·Maria Fleseriu, Stephan Petersenn
Dec 3, 2013·Pituitary·Carmen A CarrascoOscar D Bruno
Aug 6, 2014·Orphanet Journal of Rare Diseases·Niels EcksteinVladlena Pfeifer
Aug 21, 2013·Medical Molecular Morphology·Akira MatsunoR Yoshiyuki Osamura
Dec 5, 2017·Continuum : Lifelong Learning in Neurology·Roy E Strowd, Jaishri O Blakeley
Feb 3, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Ishaq KhanDeema Hussein
Mar 7, 2020·World Journal of Clinical Oncology·Lai XuJian Li Campian
Nov 29, 2015·Journal of Neuro-oncology·Marco LosaCarla Scaroni
May 17, 2018·Frontiers in Endocrinology·Fabienne LangloisMaria Fleseriu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.